December 15th, 2015

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

271.67 USD -3.87 (-1.40%)
Official Closing Price Updated: 7:09 PM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Biogen, Inc.

< Previous 1 2
...
51 52 53 54 55 56 57 58 Next >
Biogen Idec to Present at the 2007 Bear Stearns Biotech Confab Conference
From Business Wire News Releases
Biogen Idec to Present at the Sanford Bernstein 23rd Annual Strategic Decisions Conference 2007
From Business Wire News Releases
Biogen Idec Announces $3 Billion Share Repurchase Through a Modified ''Dutch Auction'' Tender Offer; Representing 16% of Shares Outstanding
From Business Wire News Releases
Elan and Biogen Idec Announce a FDA Advisory Committee Meeting to Review TYSABRI(R) for the Treatment of Crohn's Disease
From Business Wire News Releases
Stock Market Alerts: Special Alert Issued for HMIT! May 24, 2007
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Stock Market Alerts. 
From Marketwired News Releases
Biogen Idec Announces Webcast of Annual Shareholders Meeting
From Business Wire News Releases
Jacobs Receives Contract From Biogen Idec for Biotechnology Project in Denmark
From PR Newswire
Biogen Idec Announces May 17 Webcast of Research & Development Day
From Business Wire News Releases
Biogen Idec and Vernalis Plc Announce the Start of Phase II Program of BIIB014 in Parkinson's Disease
From GlobeNewswire News Releases
Biogen Idec to Present at the Baird's 2007 Growth Stock Conference
From Business Wire News Releases
Zacks Bull and Bear of the Day Highlights: Royal Caribbean, VeraSun, Biogen Idec and Shanghai Petrochemical
From Business Wire News Releases
Data Presented at the American Academy of Neurology's Annual Meeting Provide Update on Utilization and Safety of TYSABRI(R) in Patients with Multiple Sclerosis
Additional Data From Extension Study Presented Show TYSABRI Benefit is Sustained Over Three Years 
From Business Wire News Releases
Biogen Idec Reports First Quarter 2007 Results
From Business Wire News Releases
Rituxan(R) Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology
Rituxan(R) Significantly Reduced Signs Of Disease Activity As Measured By MRI and Relapse 
From Business Wire News Releases
Biogen Idec to Present at the Morgan Stanley Global Healthcare Unplugged Conference
From Business Wire News Releases
Biogen Idec to Present at the Deutsche Bank 32nd Annual Health Care Conference
From Business Wire News Releases
Biogen Idec Launches New AVONEX(R) Nurse Services Program
-- Even More Dedicated Support for the MS Community from the # 1 Prescribed MS Therapy -- 
From Business Wire News Releases
(OTC: RCAU) to Partner With Sonic Automotive Group's eCommerce Leader for eAutoDrop Franchise Development
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO Circuit. 
From Marketwired News Releases
Seven Summits Research Releases Comments on AAPL, SLB, DE, BTU, and BIIB
From PR Newswire
New One-Year Pharmacoeconomic Study Shows AVONEX(R) is Cost-Effective Relative to Other Interferon Therapies for Multiple Sclerosis
From Business Wire News Releases
HealthShares(TM) Announces Change to the HealthShares(TM) Ophthalmology Index
From PR Newswire
Biogen Idec To Report First Quarter 2007 Financial Results on May 2, 2007
From Business Wire News Releases
HealthShares(TM) Announces Change to the HealthShares(TM) Ophthalmology Index
From PR Newswire
Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients With Relapsing Multiple Sclerosis
- Anti-IL-2 receptor antibody significantly reduced the number of new or enlarged lesions compared to placebo; data to be submitted for presentation at upcoming medical meeting - 
From PR Newswire
Biogen Idec to Present at the Cowen & Company 27th Annual Healthcare Conference
From Business Wire News Releases
Oncologic Appoints Stephen T. Isaacs as President and Chief Executive Officer
From Business Wire News Releases
Morning Call Companies on the Move for Friday, February 16, 2007: Growing Network, Both Domestic and Abroad!
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Peter Antipatis of Capital Research Group Inc. 
From Marketwired News Releases
Seven Summits Research Releases Alerts on QCOM, RIMM, OXY, BIIB, and AEOS
From PR Newswire
Biogen Idec Reports Full Year and Fourth Quarter 2006 Results
From Business Wire News Releases
(OTC: LUCE) Revenue Climbs 310% - Earnings Up 466%
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO Circuit 
From Marketwired News Releases
< Previous 1 2
...
51 52 53 54 55 56 57 58 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

More ways to get to us

Medicine Hat News Twitter Twitter
Medicine Hat News Facebook Facebook
Medicine Hat News YouTube YouTube
Medicine Hat News Tumblr Tumblr

About Us

Contact the Medicine Hat News

3257 Dunmore Rd SE
Medicine Hat, AB T1B 3R2

[P] 403.527.1101
[F] 403.528.5696

Print Advertising: 403.528.5650
National Advertising: 403.528.5766
Online Advertising: 403.528.5698
Classifieds: 403.526.7653

© 1996-2015 The Medicine Hat News, A Division of Continental Newspapers Canada Ltd.